109 related articles for article (PubMed ID: 7837242)
1. Derivatives of 2-[[N-(Aminocarbonyl)-N-hydroxyamino]methyl]-1,4- benzodioxan as orally active 5-lipoxygenase inhibitors.
Satoh Y; Powers C; Toledo LM; Kowalski TJ; Peters PA; Kimble EF
J Med Chem; 1995 Jan; 38(1):68-75. PubMed ID: 7837242
[TBL] [Abstract][Full Text] [Related]
2. Substituted chromenes as potent, orally active 5-lipoxygenase inhibitors.
Satoh Y; Stanton JL; Hutchison AJ; Libby AH; Kowalski TJ; Lee WH; White DH; Kimble EF
J Med Chem; 1993 Nov; 36(23):3580-94. PubMed ID: 8246226
[TBL] [Abstract][Full Text] [Related]
3. Azole phenoxy hydroxyureas as selective and orally active inhibitors of 5-lipoxygenase.
Malamas MS; Carlson RP; Grimes D; Howell R; Glaser K; Gunawan I; Nelson JA; Kanzelberger M; Shah U; Hartman DA
J Med Chem; 1996 Jan; 39(1):237-45. PubMed ID: 8568813
[TBL] [Abstract][Full Text] [Related]
4. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
[TBL] [Abstract][Full Text] [Related]
5. CGS 22745: a selective orally active inhibitor of 5-lipoxygenase.
Kimble E; Kowalski T; White D; Raychauduri A; Pastor G; Chertock H; Lee W; Neale R; Hamdan A; Wasley J
Agents Actions; 1991 Sep; 34(1-2):125-8. PubMed ID: 1665286
[TBL] [Abstract][Full Text] [Related]
6. WY-50,295 tromethamine, a novel, orally active 5-lipoxygenase inhibitor: biochemical characterization and antiallergic activity.
Grimes D; Sturm RJ; Marinari LR; Carlson RP; Berkenkopf JW; Musser JH; Kreft AF; Weichman BM
Eur J Pharmacol; 1993 May; 236(2):217-28. PubMed ID: 8391458
[TBL] [Abstract][Full Text] [Related]
7. A-78773: a selective, potent 5-lipoxygenase inhibitor.
Bell RL; Brooks DW; Young PR; Lanni C; Stewart AO; Bouska J; Malo PE; Carter GW
J Lipid Mediat; 1993; 6(1-3):259-64. PubMed ID: 8395248
[TBL] [Abstract][Full Text] [Related]
8. Substituted thiopyrano[2,3,4-c,d]indoles as potent, selective, and orally active inhibitors of 5-lipoxygenase. Synthesis and biological evaluation of L-691,816.
Hutchinson JH; Riendeau D; Brideau C; Chan C; Delorme D; Denis D; Falgueyret JP; Fortin R; Guay J; Hamel P
J Med Chem; 1993 Sep; 36(19):2771-87. PubMed ID: 8410991
[TBL] [Abstract][Full Text] [Related]
9. Optimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors.
Bell RL; Bouska JB; Malo PE; Lanni C; Harris RR; Otis ER; Stewart AO; Brooks DW; Carter GW
J Pharmacol Exp Ther; 1995 Feb; 272(2):724-31. PubMed ID: 7853186
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 1,5-diarylpyrazol-3-propanoic acids towards inhibition of cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4 formation.
Ergün BC; Nuñez MT; Labeaga L; Ledo F; Darlington J; Bain G; Cakir B; Banoglu E
Arzneimittelforschung; 2010; 60(8):497-505. PubMed ID: 20863006
[TBL] [Abstract][Full Text] [Related]
11. 5-lipoxygenase inhibitory activity of zileuton.
Carter GW; Young PR; Albert DH; Bouska J; Dyer R; Bell RL; Summers JB; Brooks DW
J Pharmacol Exp Ther; 1991 Mar; 256(3):929-37. PubMed ID: 1848634
[TBL] [Abstract][Full Text] [Related]
12. 4-acylaminophenol derivatives as novel lipoxygenase inhibitors: synthesis and inhibitory effect on 5-lipoxygenase and leukotriene B4 production.
Kikuchi M; Hashimura Y; Tsuzurahara K; Nagasawa M; Inoue H; Taniguchi T; Uchida T
Biol Pharm Bull; 1994 Aug; 17(8):1038-46. PubMed ID: 7820104
[TBL] [Abstract][Full Text] [Related]
13. (R)-(+)-N-[3-[5-[(4-fluorophenyl)methyl]-2-thienyl]-1-methyl- 2-propynyl]-N-hydroxyurea (ABT-761), a second-generation 5-lipoxygenase inhibitor.
Brooks CD; Stewart AO; Basha A; Bhatia P; Ratajczyk JD; Martin JG; Craig RA; Kolasa T; Bouska JB; Lanni C
J Med Chem; 1995 Nov; 38(24):4768-75. PubMed ID: 7490726
[TBL] [Abstract][Full Text] [Related]
14. Leukotriene biosynthesis inhibition by aryl and aroyl substituted naphthoquinones.
Roland DM; Macchia WM; Grim KS; Kimble EF; White DH; Kowalski TJ
Agents Actions; 1991 Sep; 34(1-2):145-7. PubMed ID: 1665288
[TBL] [Abstract][Full Text] [Related]
15. Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models.
Ku EC; Raychaudhuri A; Ghai G; Kimble EF; Lee WH; Colombo C; Dotson R; Oglesby TD; Wasley JW
Biochim Biophys Acta; 1988 Apr; 959(3):332-42. PubMed ID: 2833314
[TBL] [Abstract][Full Text] [Related]
16. 5-Lipoxygenase inhibitors: synthesis and structure-activity relationships of a series of 1-aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones.
Bhatia PA; Brooks CD; Basha A; Ratajczyk JD; Gunn BP; Bouska JB; Lanni C; Young PR; Bell RL; Carter GW
J Med Chem; 1996 Sep; 39(20):3938-50. PubMed ID: 8831760
[TBL] [Abstract][Full Text] [Related]
17. Studies on 5-lipoxygenase inhibitors. II. Discovery, optical resolution and enantioselective synthesis of FR110302, a highly potent non-redox type 5-lipoxygenase inhibitor.
Yatabe T; Kayakiri H; Kawai Y; Oku T; Tanaka H
Chem Pharm Bull (Tokyo); 1998 Oct; 46(10):1556-65. PubMed ID: 9810693
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of LTB4 biosynthesis in situ by CGS 23885, a potent 5-lipoxygenase inhibitor, correlates with its pleural fluid concentrations in an experimentally induced rat pleurisy model.
Raychaudhuri A; Chertock H; Chovan J; Jones LS; Kimble EF; Kowalski TJ; Peppard J; White DH; Satoh Y; Roland D
Naunyn Schmiedebergs Arch Pharmacol; 1997 Apr; 355(4):470-4. PubMed ID: 9109363
[TBL] [Abstract][Full Text] [Related]
19. Lipoxygenase inhibitors, Part 6. Synthesis of new tetrahydropyrazine and other heterocyclic compounds by reaction of hydrazonoyl chlorides.
Frohberg P; Wiese M; Nuhn P
Arch Pharm (Weinheim); 1997 Mar; 330(3):47-52. PubMed ID: 9167446
[TBL] [Abstract][Full Text] [Related]
20. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
